Global Cancer Immunotherapy Market Analysis By Product Type (Monoclonal Antibody) Cancer Type (Lung Cancer) Colorectal Cancer, Multiple Myeloma) End Users, Forecast to 2025

Global Cancer Immunotherapy Market
The Global Cancer Immunotherapy Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.

Cancer immunotherapy (sometimes called immuno-oncology) is the use of the immune system to treat cancer. Immunotherapies can be categorized as active, passive or hybrid (active and passive). These approaches exploit the fact that cancer cells often have molecules on their surface that can be detected by the immune system, known as tumor-associated antigens (TAAs); they are often proteins or other macromolecules (e.g. carbohydrates). Active immunotherapy directs the immune system to attack tumor cells by targeting TAAs. Passive immunotherapies enhance existing anti-tumor responses and include the use of monoclonal antibodies, lymphocytes and cytokines.

The Global Cancer Immunotherapy Market is expected to reach USD 202.89 Billion by 2025, from USD 70.63 billion in 2017 growing at a CAGR of 14.1% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2017, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Global Cancer Immunotherapy Market, By Product Type (Monoclonal Antibody, Immunomodulatory, Cell Therapies, Checkpoint Inhibitors, Vaccines), By Cancer Type (Lung Cancer, Melanoma, Breast Cancer, Head And Neck Cancer, Prostate Cancer, Colorectal Cancer, Multiple Myeloma), By End Users, By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends and Forecast to 2025

Download PDF sample copy of this research report@ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-immunotherapy-market

Top Competitors:

  • Pfizer Inc,
  • Astrazeneca,
  • F. Hoffmann-La Roche LTd,
  • Bayer AG,
  • Amgen Inc,
  • Novartis AG,
  • Bristol Mayers Squibb,
  • Johnson and Johnson,
  • Merck KgaA,
  • Eli Lilly,
  • celgene Corp,
  • Gilead ,
  • bluebird bio Inc,
  • Celldex therapeutics,
  • SillaJen Inc,
  • IGNITE Immunotherapy,
  • Westeren oncolytics ltd,
  • PsiOxus Therapeutics,
  • MultiVir,
  • Vyriad,
  • Oncolys BioPharma Inc,
  • Cold genesys Inc,
  • Sorrento Therapeutics Inc,
  • Targovax,
  • Lokon therapeutics,
  • New-link genetics Corporation,
  • Ziopharma oncology,
  • Tessa therapeutics Pte Ltd,
  • Atara biotherapeutics,
  • Cellectis,
  • Oryx,
  • VCN Biosciences,
  • Orca Therapeutics B.V,
  • Daiichi Sankyo Co Ltd,
  • Ascend laboratories LLC, 
  • Transgene SA,
  • among others.

To Avail 10% Discount On This Report Mail Us on:- sopan.gedam@databridgemarketresearch.com

Major Market Drivers:

  • New technologies and combination product availability is expected to drive the market in the forecast period
  • Production of biosimilars and biobetters
  • Rising cancer suffering population
  • Increased investment in research and development of cancer immunotherapy
  • Downward pricing pressure owing to its commodity nature

Read more about this Report @ http://databridgemarketresearch.com/reports/global-cancer-immunotherapy-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sopan.gedam@databridgemarketresearch.com

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Sopan Gedam
Email: Send Email
Phone: +1-888-387-2818
Address:Office Number 402, Amanora Chambers, Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-cancer-immunotherapy-market/